GEOVAX LABS, INC. Conversion of Stock, Shares Converted
GEOVAX LABS, INC. (GOVX) reported Conversion of Stock, Shares Converted of 1.00 thousand shares for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2018-11-08
- GEOVAX LABS, INC. conversion of stock, shares converted for the quarter ending 2018-09-30 was 205.00 shares, a 70.83% increase year-over-year.
- GEOVAX LABS, INC. conversion of stock, shares converted for the quarter ending 2018-06-30 was 345.00 shares.
- GEOVAX LABS, INC. conversion of stock, shares converted for the quarter ending 2018-03-31 was 450.00 shares.
- GEOVAX LABS, INC. conversion of stock, shares converted for the quarter ending 2017-12-31 was 120.00 shares.
- GEOVAX LABS, INC. conversion of stock, shares converted for fiscal 2017 was 298.00 shares, a 142.28% increase from fiscal 2016.
- GEOVAX LABS, INC. conversion of stock, shares converted for fiscal 2016 was 123.00 shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2018-09-30 | 205.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 550.00 shares derived: sum of 2 quarters · filed 2018-11-08 | 1.00K shares 10-Q · filed 2018-11-08 | 1.12K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 345.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 795.00 shares 10-Q · filed 2018-08-07 | 915.00 shares derived: sum of 3 quarters · filed 2018-08-07 | 1.03K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | 450.00 shares 10-Q · filed 2018-05-03 | 570.00 shares derived: sum of 2 quarters · filed 2018-05-03 | 690.00 shares derived: sum of 3 quarters · filed 2018-11-08 | |
| 2017-12-31 | 120.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | 240.00 shares derived: sum of 2 quarters · filed 2018-11-08 | 298.00 shares 10-K · filed 2018-03-23 | |
| 2017-09-30 | 120.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 178.00 shares 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | 58.00 shares 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | 123.00 shares 10-K · filed 2018-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |